Literature DB >> 15322007

Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria.

Chandy C John1, Ann M Moormann, Peter O Sumba, Ayub V Ofulla, Daniel C Pregibon, James W Kazura.   

Abstract

Gamma interferon (IFN-gamma) responses to the Plasmodium falciparum antigens liver-stage antigen 1 (LSA-1) and thrombospondin-related adhesive protein (TRAP) are thought to be important in protection against malaria. Optimal methods of testing and the effects of age and transmission intensity on these responses are unknown. IFN-gamma responses to LSA-1 and TRAP peptides were assessed by the enzyme-linked immunospot assay (ELISPOT) and enzyme-linked immunosorbent assay (ELISA) in children and adults from areas of stable and unstable malaria transmission in Kenya. Adults in the areas of stable and unstable transmission had similar frequencies and levels of IFN-gamma responses to LSA-1 and TRAP as determined by ELISPOT and ELISA. In contrast, IFN-gamma responses to the LSA-1 T3 peptide (assessed by ELISPOT) and to any LSA-1 peptide (assessed by ELISA) were less frequent in children in the area of unstable transmission than in children in the area of stable transmission. IFN-gamma responses to LSA-1 were more frequently detected by ELISA than by ELISPOT in the stable-transmission area. IFN-gamma responses detected by ELISA and ELISPOT did not correlate with each other. In children in the stable-transmission area, IFN-gamma responses to LSA-1 peptides assessed by ELISA, but not by ELISPOT, were associated with protection against clinical malaria and anemia. IFN-gamma responses to LSA-1 appear to require repeated P. falciparum exposure and/or increased age and, as measured by ELISA, are associated with protection against clinical malaria and anemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322007      PMCID: PMC517451          DOI: 10.1128/IAI.72.9.5135-5142.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.

Authors:  R Wang; J Epstein; F M Baraceros; E J Gorak; Y Charoenvit; D J Carucci; R C Hedstrom; N Rahardjo; T Gay; P Hobart; R Stout; T R Jones; T L Richie; S E Parker; D L Doolan; J Norman; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection.

Authors:  Katie L Flanagan; Tabitha Mwangi; Magdalena Plebanski; Kennedy Odhiambo; Amanda Ross; Eric Sheu; Moses Kortok; Brett Lowe; Kevin Marsh; Adrian V S Hill
Journal:  Am J Trop Med Hyg       Date:  2003-04       Impact factor: 2.345

3.  ELISPOT assay for detection of peptide specific interferon-gamma secreting cells in rhesus macaques.

Authors:  A Kumar; W Weiss; J A Tine; S L Hoffman; W O Rogers
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

4.  Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Authors:  K A Bojang; P J Milligan; M Pinder; L Vigneron; A Alloueche; K E Kester; W R Ballou; D J Conway; W H Reece; P Gothard; L Yamuah; M Delchambre; G Voss; B M Greenwood; A Hill; K P McAdam; N Tornieporth; J D Cohen; T Doherty
Journal:  Lancet       Date:  2001-12-08       Impact factor: 79.321

5.  Number of cells from Plasmodium falciparum-immune donors that produce gamma interferon in vitro in response to Pf155/RESA, a malaria vaccine candidate antigen.

Authors:  L Kabilan; M Troye-Blomberg; G Andersson; E M Riley; H P Ekre; H C Whittle; P Perlmann
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children.

Authors:  P B Bloland; D A Boriga; T K Ruebush; J B McCormick; J M Roberts; A J Oloo; W Hawley; A Lal; B Nahlen; C C Campbell
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

7.  Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.

Authors:  J D Kurtis; D E Lanar; M Opollo; P E Duffy
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

8.  Anemia in parasite- and recombinant protein-immunized aotus monkeys infected with Plasmodium falciparum.

Authors:  Trevor R Jones; David F Stroncek; Alfonso S Gozalo; Nicanor Obaldia; Ellen M Andersen; Carmen Lucas; David L Narum; Alan J Magill; B K L Sim; Stephen L Hoffman
Journal:  Am J Trop Med Hyg       Date:  2002-06       Impact factor: 2.345

9.  Dyserythropoiesis and severe anaemia associated with malaria correlate with deficient interleukin-12 production.

Authors:  K Mohan; M M Stevenson
Journal:  Br J Haematol       Date:  1998-12       Impact factor: 6.998

10.  Forecasting, warning, and detection of malaria epidemics: a case study.

Authors:  Simon I Hay; Eric C Were; Melanie Renshaw; Abdisalan M Noor; Sam A Ochola; Iyabode Olusanmi; Nicholas Alipui; Robert W Snow
Journal:  Lancet       Date:  2003-05-17       Impact factor: 79.321

View more
  29 in total

1.  Impact of recombinant adenovirus serotype 35 priming versus boosting of a Plasmodium falciparum protein: characterization of T- and B-cell responses to liver-stage antigen 1.

Authors:  Ariane Rodríguez; Jaap Goudsmit; Arjen Companjen; Ratna Mintardjo; Gert Gillissen; Dennis Tax; Jeroen Sijtsma; Gerrit Jan Weverling; Lennart Holterman; David E Lanar; Menzo J E Havenga; Katarina Radosevic
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

2.  Antibodies to Plasmodium falciparum erythrocyte-binding antigen-175 are associated with protection from clinical malaria.

Authors:  Matthew B McCarra; George Ayodo; Peter O Sumba; James W Kazura; Ann M Moormann; David L Narum; Chandy C John
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Effector Phenotype of Plasmodium falciparum-Specific CD4+ T Cells Is Influenced by Both Age and Transmission Intensity in Naturally Exposed Populations.

Authors:  Michelle J Boyle; Prasanna Jagannathan; Katherine Bowen; Tara I McIntyre; Hilary M Vance; Lila A Farrington; Bryan Greenhouse; Felistas Nankya; John Rek; Agaba Katureebe; Emmanuel Arinaitwe; Grant Dorsey; Moses R Kamya; Margaret E Feeney
Journal:  J Infect Dis       Date:  2015-02-02       Impact factor: 5.226

4.  Changes in antigen-specific cytokine and chemokine responses to Plasmodium falciparum antigens in a highland area of Kenya after a prolonged absence of malaria exposure.

Authors:  Lyticia A Ochola; Cyrus Ayieko; Lily Kisia; Ng'wena G Magak; Estela Shabani; Collins Ouma; Chandy C John
Journal:  Infect Immun       Date:  2014-06-23       Impact factor: 3.441

5.  Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.

Authors:  Gregory S Noland; Brett Hendel-Paterson; Xinan M Min; Ann M Moormann; John M Vulule; David L Narum; David E Lanar; James W Kazura; Chandy C John
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

6.  Development of clinical immunity to malaria in highland areas of low and unstable transmission.

Authors:  Melissa A Rolfes; Matthew McCarra; Ng'wena G Magak; Kacey C Ernst; Arlene E Dent; Kim A Lindblade; Chandy C John
Journal:  Am J Trop Med Hyg       Date:  2012-09-17       Impact factor: 2.345

7.  Relation between vitamin B12 and folate status, and hemoglobin concentration and parasitemia during acute malaria infections in Colombia.

Authors:  Olga Caicedo; Eduardo Villamor; Yibby Forero; José Ziade; Pilar Pérez; Francisco Quiñones; Myriam Arévalo-Herrera; Sócrates Herrera
Journal:  Acta Trop       Date:  2009-12-02       Impact factor: 3.112

8.  Toll-like receptor polymorphisms in malaria-endemic populations.

Authors:  Jennifer A Greene; Ann M Moormann; John Vulule; Moses J Bockarie; Peter A Zimmerman; James W Kazura
Journal:  Malar J       Date:  2009-03-24       Impact factor: 2.979

9.  MIG (CXCL9) is a more sensitive measure than IFN-gamma of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines.

Authors:  Tamara K Berthoud; Susanna J Dunachie; Stephen Todryk; Adrian V S Hill; Helen A Fletcher
Journal:  J Immunol Methods       Date:  2008-10-24       Impact factor: 2.303

Review 10.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.